Browse All

Current Filters

CLEAR FILTER x

TITLE

The Small Molecule VQ-101 Demonstrates Sustained Lysosomal Glucocerebrosidase (GCase) Activation in Idiopathic Parkinson’s Disease

Author:Facheris, Maurizio   Siddiqui, Omer   Van der Valk, Jurrian   koopmans, ingrid   Hunt, Kevin   Hagey, Mackenzie   Jack, Beyer   Wong, Harvey   Kremer, Philip   Sullivan, James   Ysselstein, Daniel   

Session Name:S26: Movement Disorders: Clinical Trials and Therapeutics  

Topic:Movement Disorders  

Program Number:S26.005  

Author Institution:Vanqua Bio, Chicago, IL  Center for Human Drug Research, Leiden, Netherlands  University of British Columbia, Vancouver, BC, Canada  

Efficacy and Safety of Tolebrutinib Versus Placebo in Primary Progressive Multiple Sclerosis: Results from the Phase Three PERSEUS Trial

Author:Fox, Robert   Bar-Or, Amit   Vermersch, Patrick   Oreja Guevara, Celia   Traboulsee, Anthony   Giovannoni, Gavin   Syed, Sana   Sun, Furong   Salloum, Naji   Turner, Timothy   Wallstroem, Erik   Reich, Daniel   

Session Name:PL6: Contemporary Clinical Issues Plenary Session  

Topic:Multiple Sclerosis  

Program Number:PL6.003  

Author Institution:Cleveland Clinic, Cleveland, OH  University of Pennsylvania, Philadelphia, PA  University of Lille, Lille, France  Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain  University of British Columbia, Vancouver, BC, Canada  Queen Mary University London, London, United Kingdom  Sanofi , Cambridge, MA  Sanofi, Morristown, NJ  Sanofi, CHILLY-MAZARIN, France  Sanofi, Cambridge, MA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, MD  

Subgroup Analysis of the Phase Three Tolebrutinib HERCULES Trial: Disability Accumulation Outcomes in North American Participants

Author:Coyle, Patricia   Bar-Or, Amit   Reich, Daniel   Traboulsee, Anthony   Syed, Sana   Li, Ye   Vargas, Wendy   Fox, Robert   

Session Name:P9: Multiple Sclerosis: Clinical Trials 2  

Topic:Multiple Sclerosis  

Program Number:P9.003  

Author Institution:Stony Brook University Renaissance School of Medicine, Stony Brook, NY  University of Pennsylvania, Philadelphia, PA  Translational Neuroradiology Section, National Institutes of Health, Bethesda, MD  University of British Columbia, Vancouver, BC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  Cleveland Clinic, Cleveland, OH  

Redefining Landmarks: The Petrosal Process of the Sphenoid Bone and its Implications in Endoscopic Endonasal Skull Base Surgery

Author:Amani, Vania   Doroudi, Majid   Alimohammadi, Majid   

Session Name:P11: Neuro-oncology: Neurosurgery and Immunotherapy Trials  

Topic:Neuro-oncology  

Program Number:P11.008  

Author Institution:University of British Columbia, Vancouver, BC, Canada